Sridhar Kosaraju
CIK: 0001651325
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (20.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 4, 2026TXG
10x Genomics, Inc.
Award(A)Direct8.8K shares- - Jun 3, 2025TXG
10x Genomics, Inc.
Award(A)Direct15.4K shares- - Apr 3, 2025NVRO
NEVRO CORP
Disposition(D)Direct46.6K shares- - Dec 31, 2024NVRO
NEVRO CORP
Award(A)Direct4.2K shares- - Sep 30, 2024NVRO
NEVRO CORP
Award(A)Direct2.8K shares-
1-5 of 5 transactions
About Kosaraju Sridhar
Kosaraju Sridhar (SEC CIK 0001651325) files insider reports with the SEC as Director of 10x Genomics, Inc. (TXG) and Director of NEVRO CORP (NVRO).
Signal8 holds 5 ownership filings by Kosaraju Sridhar, all Form 4s, filed between Oct 2, 2024 and Jun 8, 2026. Those filings report 5 transactions, from Sep 30, 2024 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kosaraju Sridhar's filings is in PLEASANTON, CA.
Recent filings by Kosaraju Sridhar
- Jun 4, 2026: Grant or award of TXG shares (Form 4, code A).
- Jun 3, 2025: Grant or award of TXG shares (Form 4, code A).
- Apr 3, 2025: Disposition to issuer transaction of NVRO shares (Form 4, code D).
- Dec 31, 2024: Grant or award of NVRO shares (Form 4, code A).
- Sep 30, 2024: Grant or award of NVRO shares (Form 4, code A).
Other insiders filing for 10x Genomics, Inc. (TXG)
- SULIMAN SHEHNAAZ, Director
- Saxonov Serge, Chief Executive Officer
- Taich Adam, Chief Financial Officer
- STUELPNAGEL JOHN R, Director
- Hindson Benjamin J.
- Teichmann Sarah A., Director